Limited value of routine microalbuminuria assessment in multi-ethnic obese children

Nalini N E Radhakishun1, Mariska van Vliet, Ines A von Rosenstiel

  • 1Department of Pediatrics, Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. Nalini.Radhakishun@slz.nl

Insights

Microalbuminuria is uncommon in overweight children and not linked to heart disease risks. Routine screening is not recommended for asymptomatic obese youth.

Area of Science:

  • Pediatrics
  • Cardiology
  • Metabolic Health

Background:

  • Overweight and obesity in children are linked to increased cardiometabolic risk.
  • Microalbuminuria is an early marker of kidney and cardiovascular disease.

Purpose of the Study:

  • To determine the prevalence of microalbuminuria in overweight/obese children.
  • To investigate the association between microalbuminuria and cardiometabolic risk factors.

Main Methods:

  • Retrospective analysis of prospectively collected data from 408 children (3-19 years).
  • Measured anthropometrics, oral glucose tolerance, lipids, alanine aminotransferase, and urinary albumin/creatinine ratio (ACR).
  • Microalbuminuria defined by ACR thresholds specific to sex.

Main Results:

  • Low prevalence of microalbuminuria (2.7%, 11 children) observed.
  • No significant differences in prevalence across ethnicities or sexes.
  • Microalbuminuria was not associated with hypertension, impaired glucose tolerance, dyslipidemia, or elevated alanine aminotransferase.
  • A trend towards higher BMI Z-scores in children with microalbuminuria was noted (P=0.054).

Conclusions:

  • Microalbuminuria is infrequent in asymptomatic overweight and obese children.
  • No association found between microalbuminuria and key cardiometabolic risk factors in this cohort.
  • Routine screening for microalbuminuria is not supported in this population.
Abstract

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...